Peptides have become one of the most studied classes of molecules in modern biomedical research. From tissue repair to metabolic regulation, these short amino acid chains play central roles in nearly every biological process. For researchers entering the field or sourcing compounds for laboratory work, understanding what peptides are, how they function, and what distinguishes research-grade quality is essential.

Research Use Only. All information in this article is provided for educational and in vitro research purposes. Peptides discussed herein are not intended for human or animal consumption, diagnostic, or therapeutic use.

What Are Peptides?

At their most fundamental level, peptides are short chains of amino acids linked by peptide bonds. They are distinguished from proteins primarily by length: peptides typically consist of 2 to 50 amino acids, while proteins are longer polypeptide chains that fold into complex three-dimensional structures. This distinction is not always rigid -- some molecules at the boundary, such as insulin (51 amino acids), are sometimes classified as either.

The human body produces hundreds of endogenous peptides that serve as hormones, neurotransmitters, and signaling molecules. Growth hormone-releasing hormone (GHRH), for instance, is a 44-amino acid peptide that regulates growth hormone secretion from the anterior pituitary. Oxytocin, a 9-amino acid peptide, modulates social bonding and uterine contractions. Glutathione, a tripeptide, functions as the body's primary intracellular antioxidant.

Each peptide's biological activity is determined by its specific amino acid sequence, which dictates its three-dimensional shape and, consequently, which receptors it can bind. A change in even a single amino acid can dramatically alter a peptide's function, binding affinity, or half-life -- a principle that underpins much of modern peptide research and synthetic analogue development.

Natural vs. Synthetic Peptides

Endogenous peptides are those produced naturally within the body. They are synthesized by ribosomes from mRNA templates and often undergo post-translational modifications such as glycosylation, phosphorylation, or amidation before becoming biologically active. Examples include GLP-1 (glucagon-like peptide-1), thymosin beta-4, and the melanocortins.

Synthetic peptides are manufactured in the laboratory, most commonly through solid-phase peptide synthesis (SPPS) -- a method pioneered by Bruce Merrifield, for which he received the Nobel Prize in Chemistry in 1984. SPPS allows researchers to build peptides amino acid by amino acid on a solid resin support, enabling precise control over sequence, length, and purity.

Synthetic analogues are often designed to improve upon natural peptides. Common modifications include:

  • D-amino acid substitution -- replacing L-amino acids with their D-isomers to resist enzymatic degradation
  • PEGylation -- attaching polyethylene glycol chains to increase half-life
  • Cyclization -- creating circular structures for enhanced receptor binding and stability
  • Fatty acid conjugation -- as seen in Semaglutide, where a C18 fatty acid chain enables albumin binding and extends half-life

These modifications allow researchers to study peptide mechanisms with compounds that remain active long enough for meaningful experimental observation, overcoming the rapid degradation that limits many native peptides to half-lives of mere minutes.

How Peptides Work: Signaling and Receptors

Peptides exert their biological effects primarily through receptor-mediated signaling. Most peptides are too large and too hydrophilic to cross the cell membrane directly. Instead, they bind to specific receptors on the cell surface, triggering intracellular signaling cascades that alter cell behavior.

The major receptor families involved in peptide signaling include:

  • G protein-coupled receptors (GPCRs) -- the largest receptor superfamily, targeted by peptides including GLP-1, ghrelin, and the melanocortins. Upon peptide binding, GPCRs activate G proteins that regulate secondary messengers like cAMP, IP3, and DAG.
  • Receptor tyrosine kinases (RTKs) -- activated by growth factor peptides, leading to autophosphorylation and downstream MAPK or PI3K/Akt signaling.
  • Cytokine receptors -- which signal through the JAK-STAT pathway, relevant to immune-modulating peptides like thymosin alpha-1.

The specificity of peptide-receptor interaction is determined by complementary molecular geometry -- often described as a lock-and-key model, though the more accurate "induced fit" model accounts for the conformational changes that occur in both the peptide and receptor upon binding. This specificity is what makes peptides so valuable in research: each peptide activates a defined set of downstream pathways, allowing researchers to study specific biological mechanisms in isolation.

Once a peptide binds its receptor, the resulting signal can trigger diverse cellular responses: gene transcription, enzyme activation or inhibition, ion channel opening, or changes in cell motility and proliferation. The nature of the response depends on the receptor type, the cell type expressing it, and the broader signaling context.

Categories of Research Peptides

Research peptides span a wide range of biological functions. While classification schemes vary, four major categories capture the bulk of current research activity.

Recovery and Tissue Repair

Recovery peptides are among the most studied compounds in regenerative biology. They support research into wound healing, tissue remodelling, and cellular repair mechanisms. Key peptides in this category include body protection compound (BPC-157), a 15-amino acid gastric peptide that has demonstrated angiogenic and cytoprotective properties in pre-clinical models, and thymosin beta-4 (TB-500), a 43-amino acid peptide central to actin regulation and cell migration. GHK-Cu, a naturally occurring copper tripeptide, is studied for its role in collagen synthesis and gene expression modulation.

Metabolic Regulation

Metabolic peptides target energy homeostasis, glucose metabolism, and appetite regulation pathways. The incretin-based peptides have attracted significant research attention: GLP-1 receptor agonists such as Semaglutide and dual GIP/GLP-1 agonists like Tirzepatide are studied for their effects on insulin secretion, glucagon suppression, and central appetite signaling. MOTS-c, a mitochondrial-derived peptide, is studied for its role in metabolic stress response and AMPK pathway activation.

Performance and Growth Hormone Research

Growth hormone secretagogues represent a major area of peptide research. CJC-1295, a GHRH analogue, stimulates growth hormone synthesis via pituitary GHRH receptors. Ipamorelin, a selective GH secretagogue receptor agonist, promotes GH release through ghrelin receptor pathways. The combination of these two compounds -- acting on complementary receptor systems -- has been studied for synergistic pulsatile GH release patterns. Other peptides in this category include GHRP-2, GHRP-6, and hexarelin.

Longevity and Neuroprotection

Longevity-focused peptide research examines cellular aging mechanisms, telomere biology, and neuroprotective pathways. Epithalon (Ala-Glu-Asp-Gly), a synthetic tetrapeptide, is studied for its ability to activate telomerase and modulate pineal gland function. Selank, a synthetic analogue of the immunoglobulin G tuftsin fragment, is researched for its modulation of GABA, serotonin, and BDNF expression. Semax, a synthetic ACTH analogue, is studied for neurotrophic factor upregulation and cognitive pathway modulation.

Key Categories at a Glance

  • Recovery: BPC-157, TB-500, GHK-Cu, Thymosin Alpha-1
  • Metabolic: Semaglutide, Tirzepatide, MOTS-c, AOD-9604
  • Performance: CJC-1295, Ipamorelin, GHRP-2, GHRP-6
  • Longevity: Epithalon, Selank, Semax, SS-31 (Elamipretide)

While the peptide landscape is vast, certain compounds have accumulated particularly deep bodies of pre-clinical literature and remain central to ongoing research programs.

BPC-157 (Body Protection Compound-157) is a 15-amino acid pentadecapeptide derived from a protective protein isolated from gastric juice. Research has demonstrated its effects on angiogenesis, growth hormone receptor upregulation, and nitric oxide synthesis modulation. It is one of the most frequently studied peptides in tissue repair research.

Semaglutide is a 34-amino acid GLP-1 receptor agonist with a fatty acid modification that extends its half-life through albumin binding. It is studied in metabolic research for its effects on glucose-dependent insulin secretion, glucagon suppression, and central appetite regulation via hypothalamic GLP-1 receptors.

Epithalon (Epitalon) is a synthetic tetrapeptide studied for telomerase activation and circadian rhythm regulation. Originating from the St. Petersburg Institute of Bioregulation and Gerontology, it has been the subject of research examining telomere elongation in human fibroblast cultures and melatonin secretion modulation.

Tirzepatide is a dual GIP/GLP-1 receptor agonist that has generated significant research interest due to its simultaneous engagement of two incretin pathways, producing synergistic metabolic effects in research models.

PT-141 (Bremelanotide) is a melanocortin receptor agonist derived from Melanotan II. It activates MC3R and MC4R receptors in the central nervous system and is studied for its effects on melanocortin signaling pathways distinct from vascular mechanisms.

Disclaimer: The compounds described above are sold exclusively for in vitro research and laboratory applications. No statements made in this article constitute medical advice or therapeutic claims. These compounds are not approved for human or animal use.

Why Purity and HPLC Testing Matter

The value of any research peptide is directly tied to its purity. Impurities -- including truncated sequences, deletion peptides, residual reagents from synthesis, and oxidation products -- can confound experimental results, introduce variability, and compromise research validity.

High-Performance Liquid Chromatography (HPLC) is the gold standard for peptide purity assessment. In HPLC analysis, the sample is dissolved and passed through a chromatographic column under high pressure. Different molecular species separate based on their interaction with the stationary phase, eluting at characteristic retention times. A UV detector (typically at 220nm) measures the absorbance of each fraction, producing a chromatogram where peak area corresponds to compound concentration.

Purity is calculated as the percentage of total UV-absorbing area attributable to the target peptide peak. Research-grade peptides should demonstrate purity of 99% or higher by HPLC, meaning that 99% or more of the UV-absorbing material corresponds to the target compound.

Mass Spectrometry (MS) provides the complementary identity confirmation. By detecting the molecular weight of the compound and comparing it to the theoretical molecular weight (within 0.1 Da for high-resolution instruments), MS confirms that the dominant HPLC peak is indeed the target peptide rather than a similarly-sized impurity.

Together, HPLC purity and MS identity confirmation constitute a rigorous Certificate of Analysis (COA). When evaluating peptide suppliers, researchers should look for:

  • Third-party laboratory testing (not only in-house analysis)
  • Batch-specific COAs traceable to individual lot numbers
  • Both HPLC purity data and mass spectrometry confirmation
  • Accreditation of the testing laboratory (ISO/IEC 17025)
  • Chromatograms showing a single dominant peak without significant secondary peaks

Sub-standard purity introduces uncontrolled variables into experimental systems. A compound labeled at 95% purity contains 5% unknown material -- which may include biologically active truncated peptides, synthesis byproducts, or degradation products that can produce confounding effects. For reproducible, publishable research, purity matters.

Sourcing Research-Grade Peptides

Selecting a peptide supplier requires evaluating several factors beyond price: synthesis quality, analytical verification, storage and shipping conditions, and regulatory compliance. Research-grade suppliers should provide batch-specific COAs with third-party HPLC-MS verification, proper lyophilization for compound stability, and cold-chain shipping where required.

Peptiko supplies 60+ HPLC-verified research peptides at 99% or higher purity, with batch-specific COAs from accredited third-party laboratories. All compounds are lyophilized for maximum shelf stability and shipped with appropriate temperature controls.

All Peptiko products are supplied for in vitro research and laboratory use only. We do not provide medical advice, and our compounds are not intended for human or animal consumption.

Explore the Peptiko Catalog

60+ research-grade peptides. HPLC-verified purity. Batch-specific COAs.

RESEARCH USE ONLY. All products sold by Peptiko are intended exclusively for in vitro research, laboratory applications, and educational purposes. Not for human consumption. Not for diagnostic or therapeutic use. By purchasing from Peptiko, you confirm that you understand and agree to these terms.